You are here

Chiesi

Chiesi Rare Skin Disease Drug Acquired in Billion Dollar Deal Wins FDA Approval

MedCity News

Tue, 12/19/23 - 11:13 pm

epidermolysis bullosa

New treatment for Fabry disease receives key recommendation

Biopharma Reporter

Tue, 09/12/23 - 10:35 am

Chiesi Fabry disease treatment gets EU marketing authorization

Labiotech.eu

Wed, 05/10/23 - 10:06 am

Protalix BioTherapeutics

Pfizer's fortunes overshadow first-quarter dealmaking

EP Vantage

Wed, 04/12/23 - 10:22 am

The benefits of being a family-run pharma company

Pharmaforum

Wed, 09/22/21 - 11:32 pm

Switch data back Chiesi/Protalix long-acting Fabry drug

Pharmaforum

Thu, 02/25/21 - 10:01 am

Moderna lands $100M upfront in deals with Vertex, Chiesi

Fierce Biotech

Thu, 09/17/20 - 10:44 am

Moderna Therapeutics

cystic fibrosis

Vertex Pharmaceuticals

Biotech Protalix, Chiesi edge close to potential Fabry disease approval

Fierce Biotech

Thu, 05/28/20 - 10:53 am

Protalix BioTherapeutics

pegunigalsidase alfa

Chiesi starts rare diseases division, ahead of potential Fabry disease filing

Pharmaforum

Tue, 02/18/20 - 10:14 am

Chiesi buys asthma company, pitting it against Novartis

BioPharma Dive

Tue, 11/22/16 - 11:26 am

Atopix Therapeutics

Medicines Co. sells off cardiovascular drugs to Italy's Chiesi

BioPharma Dive

Mon, 05/9/16 - 01:51 pm

Medicines Company

Glaxo Tries To Turn A Triple Play

Seeking Alpha

Wed, 02/11/15 - 09:11 am

Italy's Chiesi to buy rest of Cornerstone Therapeutics

Reuters

Mon, 09/16/13 - 03:45 pm

Cornerstone Therapeutics